Horizon Therapeutics Public Ltd Co Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Horizon Therapeutics Public Ltd Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Horizon Therapeutics Public Ltd Co for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 125,000 | 0 | 250,000 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 14.56 | 57,125 | 831,740 | 446,721 | 503.8 K to 446.7 K (-11.34 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 125,000 | 0 | 503,846 | 378.8 K to 503.8 K (+32.99 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 19,250 | 0 | 38,500 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 14.56 | 8,798 | 128,099 | 192,350 | 201.1 K to 192.4 K (-4.37 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 19,250 | 0 | 201,148 | 181.9 K to 201.1 K (+10.58 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Option Exercise | M | 0.00 | 19,250 | 0 | 38,500 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Payment of Exercise | F | 14.56 | 8,798 | 128,099 | 53,869 | 62.7 K to 53.9 K (-14.04 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Chief Admin. O ... | Buy | M | 0.00 | 19,250 | 0 | 62,667 | 43.4 K to 62.7 K (+44.34 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 9,500 | 0 | 19,000 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 14.56 | 4,342 | 63,220 | 29,499 | 33.8 K to 29.5 K (-12.83 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 9,500 | 0 | 33,841 | 24.3 K to 33.8 K (+39.03 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Option Exercise | M | 0.00 | 9,500 | 0 | 19,000 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Payment of Exercise | F | 14.56 | 2,955 | 43,025 | 27,059 | 30 K to 27.1 K (-9.85 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Buy | M | 0.00 | 9,500 | 0 | 30,014 | 20.5 K to 30 K (+46.31 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 31,000 | 0 | 62,000 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 14.56 | 14,167 | 206,272 | 62,707 | 76.9 K to 62.7 K (-18.43 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 31,000 | 0 | 76,874 | 45.9 K to 76.9 K (+67.58 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 62,000 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 14.56 | 14,167 | 206,272 | 34,190 | 48.4 K to 34.2 K (-29.30 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 48,357 | 17.4 K to 48.4 K (+178.60 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 9,500 | 0 | 19,000 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 14.56 | 2,955 | 43,025 | 52,383 | 55.3 K to 52.4 K (-5.34 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 9,500 | 0 | 55,338 | 45.8 K to 55.3 K (+20.73 %) |
| Mar 07 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,025 | 0 | 31,025 | |
| Mar 07 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 16.11 | 14,268 | 229,857 | 17,357 | 31.6 K to 17.4 K (-45.12 %) |
| Mar 07 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,025 | 0 | 31,625 | 600 to 31.6 K (+5,170.83 %) |
| Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | X | 4.31 | 6,913 | 29,781 | 0 | |
| Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Sell | S | 16.00 | 30,000 | 480,000 | 95,408 | 125.4 K to 95.4 K (-23.92 %) |
| Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Sell | S | 16.48 | 1,808 | 29,796 | 125,408 | 127.2 K to 125.4 K (-1.42 %) |
| Mar 02 2017 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | X | 4.31 | 6,913 | 29,781 | 127,216 | 120.3 K to 127.2 K (+5.75 %) |